JP2022536581A5 - - Google Patents

Info

Publication number
JP2022536581A5
JP2022536581A5 JP2021561910A JP2021561910A JP2022536581A5 JP 2022536581 A5 JP2022536581 A5 JP 2022536581A5 JP 2021561910 A JP2021561910 A JP 2021561910A JP 2021561910 A JP2021561910 A JP 2021561910A JP 2022536581 A5 JP2022536581 A5 JP 2022536581A5
Authority
JP
Japan
Prior art keywords
polypeptide
amino acid
polypeptides
tmmp
terminus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021561910A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022536581A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/037919 external-priority patent/WO2020257191A1/en
Publication of JP2022536581A publication Critical patent/JP2022536581A/ja
Publication of JP2022536581A5 publication Critical patent/JP2022536581A5/ja
Pending legal-status Critical Current

Links

JP2021561910A 2019-06-19 2020-06-16 多量体ｔ細胞調節性ポリペプチド及びその使用方法 Pending JP2022536581A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962863754P 2019-06-19 2019-06-19
US62/863,754 2019-06-19
PCT/US2020/037919 WO2020257191A1 (en) 2019-06-19 2020-06-16 Multimeric t-cell modulatory polypeptides and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2022536581A JP2022536581A (ja) 2022-08-18
JP2022536581A5 true JP2022536581A5 (enExample) 2023-06-16

Family

ID=74040105

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021561910A Pending JP2022536581A (ja) 2019-06-19 2020-06-16 多量体ｔ細胞調節性ポリペプチド及びその使用方法

Country Status (4)

Country Link
US (1) US20220017597A1 (enExample)
EP (1) EP3986448A4 (enExample)
JP (1) JP2022536581A (enExample)
WO (1) WO2020257191A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017201210A1 (en) * 2016-05-18 2017-11-23 Cue Biopharma, Inc. T-cell modulatory multimeric polypeptides and methods of use thereof
ES2973548T3 (es) 2016-12-22 2024-06-20 Cue Biopharma Inc Polipéptidos multiméricos moduladores de linfocitos T y métodos para su uso
EP3565829A4 (en) 2017-01-09 2021-01-27 Cue Biopharma, Inc. T-CELL-MODULATING MULTIMERIC POLYPEPTIDES AND METHOD OF USING THEREOF
US20200010528A1 (en) 2017-03-15 2020-01-09 Cue Biopharma, Inc. Methods for modulating an immune response
JP2020534352A (ja) 2017-09-07 2020-11-26 キュー バイオファーマ，インコーポレーテッド コンジュゲーション部位を有するｔ細胞調節多量体ポリペプチド及びその使用方法
CN111886241A (zh) 2018-01-09 2020-11-03 库尔生物制药有限公司 多聚体t细胞调节多肽及其使用方法
MX2021007479A (es) * 2018-12-19 2021-09-23 Cue Biopharma Inc Polipeptidos multimericos moduladores de linfocitos t y metodos de uso de estos.
WO2021231376A2 (en) 2020-05-12 2021-11-18 Cue Biopharma, Inc. Multimeric t-cell modulatory polypeptides and methods of use thereof
WO2022056014A1 (en) 2020-09-09 2022-03-17 Cue Biopharma, Inc. Mhc class ii t-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (t1d) and methods of use thereof
MX2023008966A (es) * 2021-02-07 2023-09-29 Chia Tai Tianqing Pharmaceutical Group Co Ltd Anticuerpo biespecifico.
WO2022197970A2 (en) * 2021-03-19 2022-09-22 Cue Biopharma, Inc. T-cell modulatory polypeptides and methods of use thereof
AU2022238389A1 (en) * 2021-03-19 2023-10-05 Cue Biopharma, Inc. T-cell modulatory polypeptides and methods of use thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2289742C (en) * 1997-05-08 2013-07-16 Biomira Inc. Method for generating activated t-cells and antigen-pulsed antigen-presenting cells
US7696306B2 (en) * 2003-07-11 2010-04-13 Board of Agents of the University of Nebraska Compositions and methods for preventing or treating cancer
KR20150037959A (ko) * 2012-08-02 2015-04-08 에프. 호프만-라 로슈 아게 단량체 및 다량체 분자의 제조 방법 및 이의 용도
WO2015195531A2 (en) * 2014-06-18 2015-12-23 Albert Einstein College Of Medicine, Inc. Syntac polypeptides and uses thereof
CA2993429A1 (en) * 2015-07-31 2017-02-09 Tarveda Therapeutics, Inc. Compositions and methods for immuno-oncology therapies
CA3014466A1 (en) * 2016-03-03 2017-09-08 Cue Biopharma, Inc. T-cell modulatory multimeric polypeptides and methods of use thereof
WO2017152042A2 (en) * 2016-03-04 2017-09-08 New York University Virus vectors expressing multiple epitopes of tumor associated antigens for inducing antitumor immunity
WO2017201210A1 (en) * 2016-05-18 2017-11-23 Cue Biopharma, Inc. T-cell modulatory multimeric polypeptides and methods of use thereof
AU2017378308A1 (en) * 2016-12-13 2019-06-20 Delinia, Inc. Multivalent regulatory T cell modulators
ES2973548T3 (es) * 2016-12-22 2024-06-20 Cue Biopharma Inc Polipéptidos multiméricos moduladores de linfocitos T y métodos para su uso
US12390514B2 (en) * 2017-03-09 2025-08-19 President And Fellows Of Harvard College Cancer vaccine
US20200010528A1 (en) * 2017-03-15 2020-01-09 Cue Biopharma, Inc. Methods for modulating an immune response
EP3446702A1 (en) * 2017-08-23 2019-02-27 Medizinische Hochschule Hannover Synthetic vaccine
JP2020534352A (ja) * 2017-09-07 2020-11-26 キュー バイオファーマ，インコーポレーテッド コンジュゲーション部位を有するｔ細胞調節多量体ポリペプチド及びその使用方法
EP3678691A4 (en) * 2017-09-07 2021-06-09 Cue Biopharma, Inc. Multimeric t-cell modulatory polypeptides and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2022536581A5 (enExample)
JP2022515330A5 (enExample)
JP2022548472A5 (enExample)
IL272085B2 (en) Multimeric t-cell modulatory polypeptides and methods of use thereof
JP2021500855A5 (enExample)
JP2019512222A5 (enExample)
IL308851B1 (en) T cell modulatory multimeric polypeptides and methods of using them
JP2020511949A5 (enExample)
JP2022534846A5 (enExample)
JP2023059873A5 (enExample)
CN110785435B (zh) 与il-12和il-18的基于il-15的融合物
JP2023527049A5 (enExample)
JP2019522466A5 (enExample)
JP2017519491A5 (enExample)
JP2018525006A5 (enExample)
JP2024512470A5 (enExample)
JP2020533273A5 (enExample)
US10865243B2 (en) Chimeric antigen receptor and its use
JP2021137024A5 (enExample)
JP2022109953A5 (enExample)
JP2020514375A5 (enExample)
JP2022515331A5 (enExample)
JP2019501647A5 (enExample)
JP2023526723A5 (enExample)
CA2318482A1 (en) Il-18 receptors